This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Social Bookmarking   What's this?

Adrian Sandra Dobs, MD, MHS

JAMA. 1999;281:1326-1327.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Androgenic anabolic steroids (AASs) have been touted as either a poison or a panacea. Members of the lay community, particularly athletes, have long claimed that the anabolic steroids have muscle-building potential that results in improved physical functioning. The medical community has countered that these drugs are dangerous and are associated with multiple adverse effects. At long last, some quality clinical research is being done to determine whether AASs have any legitimate role in medical therapeutics and, if so, in which patient populations.

Anabolic steroids have been used by the medical community in rare situations. For instance, in the 1960s before recombinant human growth hormone became available, oxandrolone was used to treat short stature in Turner syndrome.¹ Most studies of boys and girls with short stature or delayed puberty showed growth acceleration but no increase in final height.^2-3 Therefore, although recombinant human growth hormone is expensive . . . [Full Text of this Article]

Author Affiliation: Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Md.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

Anabolic Effects of Nandrolone Decanoate in Patients Receiving Dialysis: A Randomized Controlled Trial
Kirsten L. Johansen, Kathleen Mulligan, and Morris Schambelan
JAMA. 1999;281(14):1275-1281.
ABSTRACT | FULL TEXT  

Resistance Exercise and Supraphysiologic Androgen Therapy in Eugonadal Men With HIV-Related Weight Loss: A Randomized Controlled Trial
Alison Strawford, Theresa Barbieri, Marta Van Loan, Elizabeth Parks, Don Catlin, Norman Barton, Richard Neese, Mark Christiansen, Janet King, and Marc K. Hellerstein
JAMA. 1999;281(14):1282-1290.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Current Concepts in Anabolic-Androgenic Steroids
Evans
Am J Sports Med 2004;32:534-542.
ABSTRACT | FULL TEXT  

Resistance Exercise and Oxandrolone for Men With HIV-Related Weight Loss
Romeyn et al.
JAMA 2000;284:176-177.
FULL TEXT